Zachary Wallace, MD, Rheumatology, Boston, MA, Massachusetts General Hospital

ZacharySWallaceMD

Rheumatology Boston, MA

Physician

Dr. Wallace is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wallace's full profile

Already have an account?

Education & Training

  • Harvard T.H. Chan School of Public HealthM.Sc., Epidemiology, 2014 - 2017
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Rheumatology, 2013 - 2015
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 2010
  • Cornell UniversityB.A., History, Distinction in All Subjects, 2002 - 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2021
  • ME State Medical License
    ME State Medical License Current
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • NIH Loan Repayment Program NIAMS, 2016
  • Nomination, Fokko van der Woude Memorial Fund Prize 17th Int’l Vasculitis and ANCA Workshop, 2015
  • Distinguished Fellow Award American College of Rheumatology, 2015
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • An international, multispecialty validation study of the IgG4-related disease responder index  
    Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart P, Karadag O,..., Arthritis Care Res, 1/18/2018
  • Barriers and facilitators of mentoring for trainees and early career investigators in rheumatology research: Current state, identification of needs, and roadmap to an ...  
    Ogdie A, Sparks JA, Angeles-Han ST, Bush K, Castelino FV, Golding A, Jiang Y, Kahlenberg JM, Kim AHJ, Lee YC, Machireddy K, Ombrello MJ, Shah AA, Wallace ZS, Nigrovic ..., Arthritis Care Res, 1/1/2018
  • Lymphomas in IgG4-related disease: clinicopathologic features in a Western population  
    Bledsoe J, Wallace ZS, Stone JH, Deshpande V, Ferry JA, Virchows Arch, 1/28/2017
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • A Trial of XmAb 5871, a Reversible Inhibitor of CD19+ Cells in IgG4-Related Disease
    Wallace Z, American College of Rheumatology Annual Meeting, San Diego, CA, 1/1/2017
  • Improved Survival with Transplantation in Granulomatosis with Polyangiitis in the United States: Data from the US Renal Data System
    Wallace Z, American College of Rheumatology Annual Meeting, San Diego, CA, 1/1/2017
  • Improved Survival with Transplantation in Systemic Lupus Erythematosus in the United States: Data from the US Renal Data System
    Wallace Z, American College of Rheumatology Annual Meeting, San Diego, CA, 1/1/2017
  • Join now to see all

Lectures

  • Cluters in IgG4-RD 
    1/1/2018
  • IgG4-Related Disease: A Rapidly Evolving Field 
    Georgetown University, Washington, DC - 1/1/2017
  • A 64-year-old man with fevers, arthralgias, and testicular pain 
    Massachusetts General Hospital - 1/1/2017
  • Join now to see all

Other

  • IgG4-Related Disease (online article) 
    Wallace ZS, Co-Author, Medscape
    1/1/2013

Authored Content

  • Reducing Glucocorticoid Duration in Anca-Associated Vasculitis: A Pilot TrialFebruary 2018

Press Mentions

  • Paying for Rheumatology Care Is Complex
    Paying for Rheumatology Care Is ComplexSeptember 25th, 2019
  • Treatment Delays Associated with Prior Authorization
    Treatment Delays Associated with Prior AuthorizationSeptember 18th, 2019
  • Study: Prior Authorizations Delay Care in Rheumatology
    Study: Prior Authorizations Delay Care in RheumatologySeptember 13th, 2019
  • Join now to see all

Grant Support

  • Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated VasculitisNIAMS2018–2023
  • Phenotypes and Biomarkers of IgG4-Related DiseaseRRF2016–2019

Professional Memberships

Hospital Affiliations